Skip to content
Nonprofiteer
← CANCER RESEARCH INSTITUTE INC

Form 990 for tax year 2022

Filed by CANCER RESEARCH INSTITUTE INC.

Totals

Total revenue
$32,295,259
Total expenses
$38,552,663
Contributions and grants received
$31,020,217
Grants paid
$27,521,822
Program service revenue
$0
Investment income
$1,191,003
Other revenue
$84,039
Total assets, end of year
$138,008,864
Total liabilities, end of year
$70,013,010
Net assets or fund balances, end of year
$67,995,854
Program services expenses (Part IX)
$32,845,229
Management and general expenses
$2,079,619
Fundraising expenses
$3,627,815
Program service expenses (Part III)
$32,845,229

Program services were 85.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $573,941

  • 1c · Fundraising events

    $1,297,284

  • 1f · All other contributions, gifts and grants

    $29,148,992

  • 1g · Noncash contributions included above

    $574,281

  • 3 · Investment income

    total $644,951 · excluded $644,951

  • 6a · Gross rents

    real property $168,009

  • 6b · Less rental expenses

    real property $138,690

  • 6c · Rental income or loss

    real property $29,319

  • 6d · Net rental income or loss

    total $29,319 · excluded $29,319

  • 7a · Gross sales of assets other than inventory

    securities $20,050,443

  • 7b · Less cost or other basis and sales expenses

    securities $19,504,391

  • 7c · Gain or loss

    securities $546,052

  • 7d · Net gain or loss

    total $546,052 · excluded $546,052

  • 8a · Fundraising events: gross income

    $102,848

  • 8a · Fundraising events: contributions included on line 1c

    $1,297,284

  • 8b · Fundraising events: direct expenses

    $102,848

  • 8c · Net income from fundraising events

    total $0

  • 11a · Other revenue: MISCELLANEOUS REVENUE

    total $54,720 · related or exempt $54,720

  • 11e · Other revenue, total

    $54,720

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $25,067,892 · program services $25,067,892

  • 3 · Grants to foreign organizations and individuals

    total $2,453,930 · program services $2,453,930

  • 5 · Compensation of officers, directors and key employees

    total $2,353,418 · program services $844,830 · management and general $613,684 · fundraising $894,904

  • 7 · Other salaries and wages

    total $1,675,895 · program services $596,534 · management and general $190,044 · fundraising $889,317

  • 8 · Pension plan contributions

    total $314,864 · program services $116,963 · management and general $72,737 · fundraising $125,164

  • 9 · Other employee benefits

    total $748,601 · program services $286,807 · management and general $146,686 · fundraising $315,108

  • 10 · Payroll taxes

    total $237,590 · program services $86,251 · management and general $45,366 · fundraising $105,973

  • 11b · Fees: legal

    total $18,783 · program services $11,713 · management and general $7,070

  • 11c · Fees: accounting

    total $100,926 · management and general $100,926

  • 11f · Fees: investment management

    total $441,768 · management and general $441,768

  • 11g · Fees: other

    total $1,014,995 · program services $622,192 · management and general $15,500 · fundraising $377,303

  • 12 · Advertising and promotion

    total $224,254 · program services $55,941 · fundraising $168,313

  • 13 · Office expenses

    total $258,995 · program services $89,929 · management and general $68,060 · fundraising $101,006

  • 16 · Occupancy

    total $467,073 · program services $197,004 · management and general $107,427 · fundraising $162,642

  • 17 · Travel

    total $147,021 · program services $65,163 · management and general $24,475 · fundraising $57,383

  • 19 · Conferences, conventions and meetings

    total $2,187,368 · program services $2,187,368

  • 22 · Depreciation, depletion and amortization

    total $41,992 · program services $16,797 · management and general $9,238 · fundraising $15,957

  • 23 · Insurance

    total $51,609 · management and general $51,609

  • 24a · Other expenses: EQUIPMENT RENTAL AND MA

    total $448,588 · program services $112,465 · management and general $33,051 · fundraising $303,072

  • 24b · Other expenses: MISCELLANEOUS

    total $181,013 · program services $24,161 · management and general $127,149 · fundraising $29,703

  • 24c · Other expenses: PRINTING AND PUBLICATIO

    total $91,259 · program services $9,289 · fundraising $81,970

  • 24d · Other expenses: FILING FEE

    total $24,829 · management and general $24,829

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $14,456,208 · end of year $14,783,358

  • 2 · Savings and temporary cash investments

    beginning of year $0 · end of year $1,903,578

  • 3 · Pledges and grants receivable

    beginning of year $28,317,202 · end of year $25,188,717

  • 4 · Accounts receivable

    beginning of year $39,970 · end of year $160,297

  • 9 · Prepaid expenses and deferred charges

    beginning of year $426,189 · end of year $288,340

  • 10a · Land, buildings and equipment: cost or other basis

    $671,733

  • 10b · Land, buildings and equipment: accumulated depreciation

    $558,617

  • 10c · Land, buildings and equipment, net

    beginning of year $142,209 · end of year $113,116

  • 11 · Investments: publicly traded securities

    beginning of year $22,457,949 · end of year $26,380,379

  • 12 · Investments: other securities

    beginning of year $64,598,585 · end of year $66,740,812

  • 15 · Other assets

    beginning of year $0 · end of year $2,450,267

  • 17 · Accounts payable and accrued expenses

    beginning of year $712,546 · end of year $667,567

  • 18 · Grants payable

    beginning of year $62,989,463 · end of year $66,778,175

  • 25 · Other liabilities

    beginning of year $31,541 · end of year $2,567,268

  • 27 · Net assets without donor restrictions

    beginning of year $42,501,270 · end of year $44,693,823

  • 28 · Net assets with donor restrictions

    beginning of year $24,203,492 · end of year $23,302,031

Mission and programs · 2022

Mission

SEE SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BYFUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FORALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY, TRANSLATIONAL, AND CLINICAL RESEARCH EFFORTS AIMED AT LEARNING HOW TO HARNESS THE POWER OF THE IMMUNE SYSTEM TO DIAGNOSE, TREAT, AND CURE CANCER. CRI ALSO COORDINATES SCIENTIFIC, MEDICAL, AND PATIENT EDUCATION CONFERENCES ON THE SUBJECTS OF IMMUNOLOGY AND IMMUNOTHERAPY, AND DISSEMINATES INFORMATION IN ENGLISH AND SPANISH ABOUT ADVANCES IN TUMOR IMMUNOLOGY TO THE MEDIA, PUBLIC, AND MEDICAL AND SCIENTIFIC COMMUNITIES.

Activities or mission (Part I)

SEE ON SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BYFUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FORALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY,TRANSLATIONAL, AND CLINICAL RESEARCH.

  • CLINICAL ACCELERATOR GRANTS PROGRAM - SEE SCHEDULE OTHE CRI ANNA-MARIA KELLEN CLINICAL ACCELERATOR : IS AN ACTIVELY MANAGED VENTURE PHILANTHROPY PROGRAM DESIGNED TO SPEED THE DEVELOPMENT OF PROMISING NEW CANCER IMMUNOTHERAPY COMBINATIONS. THIS MODEL FACILITATES RESEARCH COLLABORATION ACROSS LEADING BIOPHARMA COMPANIES AND THE CRI NETWORK OF IMMUNO-ONCOLOGY EXPERTS. THE PROGRAM INCLUDES PLATFORM CLINICAL TRIALS THAT ARE COLLABORATIVE, INTEGRATIVE, SCIENCE/DATA-DRIVEN, AND HYPOTHESIS-ANSWERING CLINICAL STUDIES. CRI PLANS, IMPLEMENTS, INVESTS IN, AND MANAGES EACH CLINICAL ACCELERATOR CLINICAL TRIAL AND WORKS CLOSELY WITH ACADEMIC RESEARCHER AND INDUSTRY PARTNERS ON SUCH STUDIES. EACH CLINICAL TRIAL AND PHILANTHROPIC INVESTMENT BRINGS A POTENTIAL NEW CANCER TREATMENT CLOSER TO PATIENTS, EMPOWERS ACADEMIC RESEARCHERS TO WORK MORE CLOSELY WITH INDUSTRY, AND CREATES A POTENTIAL RETURN ON INVESTMENT TO BE USED TO SUPPORT FURTURE CLINICAL EFFORTS.

    Expenses $6,843,957 · Grants $6,843,957

  • FELLOWSHIP PROGRAM - SEE SCHEDULE OTHE CRI POSTDOCTORAL FELLOWSHIP PROGRAM INCLUDES THREE TRACKS OF FELLOWSHIPS PROVIDING CAREER DEVELOPMENT, TRAINING, AND DIVERSITY BUILDING IN IMMUNOLOGY AND IMMUNO-INFOMATICS. THE CRI IRVINGTON POSTDOCTORAL FELLOWSHIP, CRI IRVINGTON POSTDOCTORAL FELLOWSHIP TO PROMOTE RACIAL DIVERSITY, AND THE CRI IMMUNO-INFORMATICS FELLOWSHIP EACH SUPPORT YOUNG IMMUNOLOGISTS AND CANCER IMMUNOLOGISTS AT TOP UNIVERSITIES AND RESEARCH CENTERS AROUND THE WORLD. FELLOWS RECEIVE UP TO $243,000 OVER THREE YEARS TO COVER THE COST OF STIPEND, INCLUDING AN INSTITUTIONAL ALLOWANCE TO HELP PAY FOR THE FELLOW'S RESEARCH SUPPLIES, TRAVEL TO SCIENTIFIC MEETINGS, HEALTH INSURANCE, AND/OR CHILDCARE. OF THE MORE THAN 1,550 CRI POSTDOCTORAL FELLOWS FUNDED TO DATE, MANY HAVE SINCE BECOME HEADS OF MAJOR MEDICAL RESEARCH INSTITUTES, ACADEMIC LEADERS IN PRESTIGIOUS UNIVERSITIES, AND ADMIRED MENTORS TO THE NEXT GENERATION OF IMMUNOLOGISTS AND TUMOR IMMUNOLOGISTS.

    Expenses $6,572,476 · Grants $6,572,476

  • STAR PROGRAM - SEE SCHEDULE OTHE LLOYD J. OLD STAR PROGRAM, LAUNCHED IN 2019, PROVIDES GRANTS OF $1.25 MILLION OVER 5 YEARS TO MID-CAREER SCIENTISTS. THIS LONGTERM FUNDING IS NOT TIED TO A SPECIFIC RESEARCH PROJECT, BUT RATHER AIMS TO PROVIDE A DEGREE OF FLEXIBILITY AND FREEDOM FOR INVESTIGATORS TO EXPLORE OUTSIDE-THE-BOX AND DISRUPTIVE AVENUES OF RESEARCH. CANDIDATES SELECTED FOR THIS AWARD ARE EXPECTED TO BE FUTURE "STARS" IN THE FIELD OF CANCER IMMUNOLOGY: SCIENTISTS TAKING RISKS.

    Expenses $6,250,000 · Grants $6,250,000

  • Withheld by Nonprofiteer: this text may name a private individual.

    Expenses $13,178,796 · Grants $7,855,389

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Listed in Part VII

  • Paul C Shiverick

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    4
  • Andrew K Tsai

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    4
  • Edgar R Berner

    VICE CHAIRMAN

    Total calculated
    $0
    Hours/week
    3
  • Donald J Gogel

    VICE CHAIRMAN

    Total calculated
    $0
    Hours/week
    3
  • Andrew M Paul

    VICE CHAIRMAN

    Total calculated
    $0
    Hours/week
    3
  • Geoffrey O Coley

    TREASURER

    Total calculated
    $0
    Hours/week
    3
  • Thomas G Mendell

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Tony Alvarez II

    TRUSTEE

    Total calculated
    $0
    Hours/week
    0.5
  • Yacov Arnopolin

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Peter L Bloom

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Brian J Brille

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Michael R Crawford

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • W Robert Dahl

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Glenn J Desimone

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Sean P Fahey

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Margot E Freedman

    TRUSTEE

    Total calculated
    $0
    Hours/week
    0.5
  • William S Goldberg

    TRUSTEE

    Total calculated
    $0
    Hours/week
    0.5
  • Oliver R Grace Jr

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Sandra Coudert Graham

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Michael M Kellen

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Sarah Kim

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Mitra Lohrasbpour

    TRUSTEE (THRU 1/2023)

    Total calculated
    $0
    Hours/week
    2
  • Alexander P Lynch

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Alex Mishurov

    TRUSTEE

    Total calculated
    $0
    Hours/week
    0.5
  • Michael J Petrick

    TRUSTEE

    Total calculated
    $0
    Hours/week
    0.5
  • Lief D Rosenblatt

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Frank Vsica

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • James A Stern

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Robert S Stolar

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Michael B Targoff

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Diane Tuft

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Lauren Sveronis

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Ronald G Weiner

    TRUSTEE

    Total calculated
    $0
    Hours/week
    1
  • Jim Weiss

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Peter Zhou

    TRUSTEE

    Total calculated
    $0
    Hours/week
    2
  • Jill O'Donnell-Tormey PhD

    CEO/DIR. OF SCIENTIFIC AFFAIRS

    Total calculated
    $602,303
    From this org
    $531,286
    From related orgs
    $0
    Other
    $71,017
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $531,286
    Bonus
    $0
    Other
    $0
    Deferred
    $34,500
    Nontaxable benefits
    $36,517
    Filer's total
    $602,303
  • Alfred R Massidas

    CFO/DIR. OF HUMAN RESOURCES

    Total calculated
    $425,801
    From this org
    $342,586
    From related orgs
    $0
    Other
    $83,215
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $342,586
    Bonus
    $0
    Other
    $0
    Deferred
    $31,250
    Nontaxable benefits
    $51,965
    Filer's total
    $425,801
  • Lynne A Rapino

    CHIEF PROGRAM OFFICER

    Total calculated
    $364,304
    From this org
    $283,374
    From related orgs
    $0
    Other
    $80,930
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $283,374
    Bonus
    $0
    Other
    $0
    Deferred
    $29,000
    Nontaxable benefits
    $51,930
    Filer's total
    $364,304
  • Jay R Campbell

    MANAGING DIR. OF CRI CLINICAL ACCELERATOR AND VENT

    Total calculated
    $355,403
    From this org
    $274,937
    From related orgs
    $0
    Other
    $80,466
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $274,937
    Bonus
    $0
    Other
    $0
    Deferred
    $28,500
    Nontaxable benefits
    $51,966
    Filer's total
    $355,403
  • Sharon S Slade

    CHIEF MARKETING OFFICER

    Total calculated
    $305,510
    From this org
    $259,188
    From related orgs
    $0
    Other
    $46,322
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $259,188
    Bonus
    $0
    Other
    $0
    Deferred
    $27,500
    Nontaxable benefits
    $18,822
    Filer's total
    $305,510
  • Brian M Brewer

    CHIEF COMMUNICATIONS OFFICER

    Total calculated
    $247,599
    From this org
    $206,106
    From related orgs
    $0
    Other
    $41,493
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $206,106
    Bonus
    $0
    Other
    $0
    Deferred
    $10,937
    Nontaxable benefits
    $30,556
    Filer's total
    $247,599
  • Rupinder Kaur

    CHIEF INFORMATION OFFICER

    Total calculated
    $285,488
    From this org
    $224,014
    From related orgs
    $0
    Other
    $61,474
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $224,014
    Bonus
    $0
    Other
    $0
    Deferred
    $25,000
    Nontaxable benefits
    $36,474
    Filer's total
    $285,488
  • Qing Hua Zhang

    CONTROLLER

    Total calculated
    $191,795
    From this org
    $140,888
    From related orgs
    $0
    Other
    $50,907
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $140,888
    Bonus
    $0
    Other
    $0
    Deferred
    $14,600
    Nontaxable benefits
    $36,307
    Filer's total
    $191,795
  • Marla S Lawson

    ASSOC. DIR. OF CORPORATE AND FOUNDATION RELATIONS

    Total calculated
    $180,363
    From this org
    $130,597
    From related orgs
    $0
    Other
    $49,766
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $130,597
    Bonus
    $0
    Other
    $0
    Deferred
    $13,500
    Nontaxable benefits
    $36,266
    Filer's total
    $180,363
  • Samik K Upadhaya

    ASST. DIR. OF SCIENTIFIC AFFAIRS

    Total calculated
    $181,057
    From this org
    $130,644
    From related orgs
    $0
    Other
    $50,413
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $130,644
    Bonus
    $0
    Other
    $0
    Deferred
    $14,100
    Nontaxable benefits
    $36,313
    Filer's total
    $181,057
  • Brian R Leidy

    CHIEF DEVELOPMENT OFFICER

    Total calculated
    $228,615
    From this org
    $199,545
    From related orgs
    $0
    Other
    $29,070
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $199,545
    Bonus
    $0
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $29,070
    Filer's total
    $228,615
  • Deanne T Marbach

    DIRECTOR OF MAJOR GIFTS

    Total calculated
    $201,124
    From this org
    $149,175
    From related orgs
    $0
    Other
    $51,949
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $149,175
    Bonus
    $0
    Other
    $0
    Deferred
    $15,600
    Nontaxable benefits
    $36,349
    Filer's total
    $201,124

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Form 990 of other organizations
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Fundraising and gaming

From Schedule G of this return, as filed.

Had an agreement with a professional fundraiser (line 2a)
Not answered

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Line Event 1 THROUGH THE KITCHEN Event 2 LANDESMAN LADIES NIGHT OUT Other events 2 events Total
Gross receipts (line 1) $952,008 $279,616 $168,508 $1,400,132
Less contributions (line 2) $849,160 $279,616 $168,508 $1,297,284
Gross income (line 3) $102,848 — — $102,848
Cash prizes (line 4) — — — —
Noncash prizes (line 5) — — — —
Rent and facility costs (line 6) — — — —
Food and beverages (line 7) — — — —
Entertainment (line 8) — — — —
Other direct expenses (line 9) $102,848 — — $102,848
Direct expenses (line 10)
$102,848
Net income (line 11)
$0

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$67,960,653

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS — $1,058,274
EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS — $1,177,356
NORTH AMERICA 0 0 GRANTS TO RECIPIENTS — $218,300
CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 INVESTMENTS — $63,617,257
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 INVESTMENTS — $1,889,466

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EAST ASIA AND THE PACIFIC $200,000 ACH/WIRE $0 — —
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, $658,274 ACH/WIRE $0 — —
EAST ASIA AND THE PACIFIC $200,000 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $200,000 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $200,000 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $200,000 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $200,000 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $243,000 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $102,256 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $17,300 ACH/WIRE $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $14,800 ACH/WIRE $0 — —
NORTH AMERICA $202,800 ACH/WIRE $0 — —
NORTH AMERICA $15,500 ACH/WIRE $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
13
Other grantees (Part II line 3)
0
Transferred property to a foreign corporation during the year (line 1)
Yes
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
Yes
Had operations in or related to a boycotting country (line 6)
No

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related partnerships

Part III: related organizations taxable as a partnership, with the filer's share.

  • CANCER VACCINE ACCELERATION CO

    RESEARCH · DE · 50% owned · general or managing partner

    Directly controlled by CRI

Provenance

Return type
form_990
Tax year
2022
Filed
18 March 2024
IRS schema version
2022v5.0
Source object
202440789349300344

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.